Catalyst
Slingshot members are tracking this event:
Ardelyx (ARDX) Presents Top-Line Phase 3 Results Evaluating Tenapanor in End-Stage Renal Disease (ESRD) with Hyperphosphatemia
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ARDX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 15, 2017
Related Projects
- Discussing the Phase 3 Tenapanor results in Hyperphosphatemia for patients with CKD on dialysis. ARDX, KERX Executed On: Apr 14, 2020 at 10:30 AM EDT
Related Keywords
Phase 3, Tenapanor, End-stage Renal Disease, Esrd, Hyperphosphatemia
